Volume 13, Issue 4 (2-2000)                   Med J Islam Repub Iran 2000 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
SHAHRIARI H, SALEHI A. EFFECT OF INTRAOCULAR POVIDONE-IODINE SOLUTION IN PREVENTION OF BACTERIAL ENDOPHTHALMITIS IN A RABBIT MODEL. Med J Islam Repub Iran 2000; 13 (4) :311-314
URL: http://mjiri.iums.ac.ir/article-1-928-en.html
EFFECT OF INTRAOCULAR POVIDONE-IODINE SOLUTION IN PREVENTION OF BACTERIAL ENDOPHTHALMITIS IN A RABBIT MODEL
HA SHAHRIARI , A SALEHI
From the Dept. of Ophthalmology, Zahedan University of Medical Sciences, Dr Shariati Ave, Zahedan, 98134, I.R. Iran.
Abstract:   (4114 Views)
In order to determine the effects of intraocular 0.05% povidone-iodine preparation in the prevention of bacterial endophthalmitis in a rabbit model, 28 albino rabbits were randomly assigned to 4 equal groups. A concentration of 5x 108 organisms (0.03 mL) in logarithmic growth phase of S. epidermidis, S. aureus, Proteus mirabilis and Pseudomonas aeruginosa, were injected separately in the anterior chamber of right and left eyes of each group. Then 0.03 mL of 0.05% povidone-iodine solution was injected in the left eyes. Eye examinations were performed with a slit-lamp daily for two weeks following injection. From 28 eyes injected with bacteria and povidone-iodine, 20 cases did not develop endophthalrnitis, one developed mild, one developed moderate, and 6 developed severe endophthalmitis. In comparison, from 28 eyes injected with bacteria and balanced salt solution, 9 cases developed mild, 10 developed moderate and 9 developed severe endophthalmitis (p<0.00 1) . Povidone-iodine solution is therefore effective in prevention of bacterial endophthalmitis, although its efficacy has a direct relationship to the bacteria type and species.
Full-Text [PDF 289 kb]   (2369 Downloads)    
Type of Study: Original Research: Basic Science in Medicine | Subject: Ophthalmology
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.